Effector Therapeutics Inc. logo

Effector Therapeutics Inc. Share Price Today (NASDAQ: EFTR)

Effector Therapeutics Inc. share price is $0 & ₹0.00 as on 19 Sep 2024 IST

Market is closed - opens 7 PM, 01 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 20 Sep 2024

View live Effector Therapeutics Inc. share price in Dollar and Rupees. Guide to invest in Effector Therapeutics Inc. stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Effector Therapeutics Inc., along with analyst recommendations, forecasts, and comprehensive financials.

Effector Therapeutics Inc. (EFTR) Key Statistics

in dollars & INR

Previous Close
$3.0E-4
Open
$2.0E-4
Market Capitalization
$203.5K
Today's Volume
$4.0K
Revenue TTM
$675.0K
EBITDA
$-32.6M
Earnings Per Share (EPS)
$-12.57
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-946.56%

How to invest in Effector Therapeutics Inc. Stock (EFTR) from India?

It is very easy for Indian residents to invest directly in Effector Therapeutics Inc. from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Effector Therapeutics Inc. stock in both Indian Rupees (INR) and US Dollars (USD). Search for Effector Therapeutics Inc. or EFTR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Effector Therapeutics Inc. or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Effector Therapeutics Inc. shares which would translate to null fractional shares of Effector Therapeutics Inc. as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Effector Therapeutics Inc., in just a few clicks!

Global Institutional Holdings in Effector Therapeutics Inc.

  • Sabby Management LLC

    7.48%

  • The Carlyle Group Inc

    4.10%

  • UBS Group AG

    1.31%

  • Geode Capital Management, LLC

    0.54%

  • Vanguard Group Inc

    0.53%

  • HRT FINANCIAL LLC

    0.46%

Analyst Recommendation on Effector Therapeutics Inc.

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Effector Therapeutics Inc.(by analysts ranked 0 to 5 stars)

About Effector Therapeutics Inc.

eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E; and collaboration agreement with the Dana-Farber Cancer Institute on a Phase 2 clinical trial, evaluating Zotatifin as combination treatment in ER+ endometrial cancer and in low grade serous ovarian cancer. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
Organization
Effector Therapeutics Inc.
Employees
14
CEO
Mr. Craig R. Jalbert CIRA
Industry
Miscellaneous

Important FAQs about investing in EFTR Stock from India :

Can Indians buy Effector Therapeutics Inc. shares?

Yes, Indians can invest in the Effector Therapeutics Inc. (EFTR) from India.

With INDmoney, you can buy Effector Therapeutics Inc. at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Effector Therapeutics Inc. at zero transaction cost.

How can I buy Effector Therapeutics Inc. shares from India?

It is very easy to buy Effector Therapeutics Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Effector Therapeutics Inc. (EFTR) be purchased?

Yes, you can buy fractional shares of Effector Therapeutics Inc. with INDmoney app.

What are the documents required to start investing in Effector Therapeutics Inc. stocks?

To start investing in Effector Therapeutics Inc., You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Effector Therapeutics Inc.?

Today's market capitalisation of Effector Therapeutics Inc. EFTR is 203.5K

Who is the Chief Executive Officer (CEO) of Effector Therapeutics Inc. ?

Mr. Craig R. Jalbert CIRA is the current Chief Executive Officer (CEO) of Effector Therapeutics Inc..